Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    eFFECTOR Therapeutics Inc...

    OTC: EFTR · Real-Time Price · USD
    0.00
    -0.00 (-100.00%)
    At close: Mar 06, 2025, 9:31 AM

    eFFECTOR Therapeutics Statistics

    Share Statistics

    eFFECTOR Therapeutics has 4.7M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 4.7M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 1.28%

    Shares Floating

    n/a
    		 4.66M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 91.62K, so undefined% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 91.62K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 2.17%

    Short Ratio (days to cover)

    n/a
    		 0.97

    Valuation Ratios

    The PE ratio is -0.71 and the forward PE ratio is null. eFFECTOR Therapeutics's PEG ratio is -0.01.

    PE Ratio

    n/a
    		 -0.71

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -4.41

    P/FCF Ratio

    n/a
    		 -0.86

    PEG Ratio

    n/a
    		 -0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for eFFECTOR Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.77, with a Debt / Equity ratio of -3.55.

    Current Ratio

    n/a
    		 0.77

    Quick Ratio

    n/a
    		 0.77

    Debt / Equity

    n/a
    		 -3.55

    Debt / EBITDA

    n/a
    		 -0.61

    Debt / FCF

    n/a
    		 -0.69

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,557,928.57

    Employee Count

    n/a
    		 14

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.43, so eFFECTOR Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.43

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0

    200-Day Moving Average

    n/a
    		 0.04

    Relative Strength Index (RSI)

    n/a
    		 36.29

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -22.92M

    Operating Income

    n/a
    		 -33.84M

    Net Income

    n/a
    		 -35.81M

    EBITDA

    n/a
    		 -33.73M

    EBIT

    n/a
    		 -38.73M

    Earnings Per Share (EPS)

    n/a
    		 -16.37
    Full Income Statement

    Balance Sheet

    The company has 14.88M in cash and 20.55M in debt, giving a net cash position of -5.67M.

    Cash & Cash Equivalents

    n/a
    		 14.88M

    Total Debt

    n/a
    		 20.55M

    Net Cash

    n/a
    		 -5.67M

    Retained Earnings

    n/a
    		 -179.38M

    Total Assets

    n/a
    		 27.13M

    Working Capital

    n/a
    		 681K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.55M and capital expenditures -97K, giving a free cash flow of -29.65M.

    Operating Cash Flow

    n/a
    		 -29.55M

    Capital Expenditures

    n/a
    		 -97K

    Free Cash Flow

    n/a
    		 -29.65M

    FCF Per Share

    n/a
    		 -13.56
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    EFTR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for EFTR.

    Price Target

    n/a
    		 $24

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 12, 2024. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Jan 12, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -13.63

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist